Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692692010 | Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3692694011 | Product containing precisely apraclonidine (as apraclonidine hydrochloride) 5 milligram/1 milliliter conventional release eye drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Is a | Product containing apraclonidine (medicinal product) | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Is a | Product containing apraclonidine (medicinal product) | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has active ingredient | Substance with central alpha adrenergic receptor agonist mechanism of action | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has active ingredient | Apraclonidine hydrochloride | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Is a | Product manufactured as ocular dose form (product) | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has manufactured dose form | Conventional release intraocular solution | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has active ingredient | Centrally acting hypotensive agent (substance) | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has manufactured dose form | Eye drops | true | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has precise active ingredient | Apraclonidine hydrochloride | true | Inferred relationship | Some | 1 | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has concentration strength numerator value | 5 | false | Inferred relationship | Some | 1 | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has basis of strength substance (attribute) | Apraclonidine (substance) | true | Inferred relationship | Some | 1 | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Is a | Apraclonidine only product in ocular dose form | true | Inferred relationship | Some | ||
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Plays role | Antiglaucoma therapeutic role | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR